PHP
NSPR icon

Parkman Healthcare Partners’s InspireMD NSPR Stock Holding History

Parkman Healthcare Partners’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Hold
2,416,518
– – 0.17% 71
2026
Q1 		$3.94M Hold
2,416,518
– – 0.41% 67
2025
Q4 		$4.3M Sell
2,416,518
-24,115
-1% -$50.3K 0.41% 66
2025
Q3 		$5.88M Buy
2,440,633
+1,205,328
+98% +$2.92M 0.61% 58
2025
Q2 		$2.8M Buy
1,235,305
+63,889
+5% +$159K 0.32% 73
2025
Q1 		$3.15M Buy
1,171,416
+316,700
+37% +$896K 0.37% 64
2024
Q4 		$2.25M Buy
854,716
+750,635
+721% +$2.02M 0.3% 67
2024
Q3 		$279K Buy
+104,081
New +$284K 0.04% 93

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Parkman Healthcare Partners's NSPR Position: Q2 2026 in Review

Parkman Healthcare Partners held its InspireMD (NSPR) position steady in Q2 2026 at 2,416,518 shares worth $1.69M. The position accounts for 0.17% of the portfolio, ranked #71.

Parkman Healthcare Partners first reported a position in NSPR in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.88M in Q3 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Parkman Healthcare Partners held 2,416,518 shares of InspireMD worth $1.69M as of Q2 2026.
  • Parkman Healthcare Partners left its InspireMD share count unchanged in Q2 2026.
  • InspireMD made up 0.17% of Parkman Healthcare Partners's portfolio in Q2 2026, its #71 holding.
  • Parkman Healthcare Partners first reported a position in InspireMD in Q3 2024 and has held it in 8 quarters since.
  • Parkman Healthcare Partners's InspireMD position peaked at $5.88M in Q3 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.